Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus.
Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France.|Centre Hospitalier Universitaire, Clermont-Ferrand, France.
T
T
Faïs
Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France.
A
A
Cougnoux
Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France.
G
G
Dalmasso
Department of Clinical Microbiology, Northern Hospital Group, Hospices Civils de Lyon, Lyon, France.|International Centre for Research in Infectious Diseases (CIRI), INSERM U1111, CNRS UMR5308, Université Lyon 1, ENS Lyon, Lyon, France.|National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France.|Claude Bernard University Lyon 1, Villeurbanne, France.
F
F
Laurent
Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France.|Centre Hospitalier Universitaire, Clermont-Ferrand, France.
J
J
Delmas
Microbes, Intestine, Inflammation and Host Susceptibility, INSERM U1071, INRA USC2018, Université Clermont Auvergne, Clermont-Ferrand, France rbonnet@chu-clermontferrand.fr.|Centre Hospitalier Universitaire, Clermont-Ferrand, France.
R
R
Bonnet
D000900:Anti-Bacterial Agents; D004926:Escherichia coli / Q000502:physiology*; D056265:Microbial Interactions; D013211:Staphylococcus aureus / Q000502:physiology*
D000900:Anti-Bacterial Agents